Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Analytical Biochemistry

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.AB.2004.05.039PMID 15301953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units.

  2003cited by this paper
• Alpha-keto amides as inhibitors of histone deacetylase.

  2003cited by this paper
• Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice

  2003cited by this paper
• Heterocyclic ketones as inhibitors of histone deacetylase.

  2003cited by this paper
• Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases

  2003cited by this paper
• α-Keto amides as inhibitors of histone deacetylase

  2003cited by this paper
• Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.

  2003cited by this paper
• Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases.

  2003cited by this paper
• Structural Identification of 2′- and 3′-O-Acetyl-ADP-ribose as Novel Metabolites Derived from the Sir2 Family of β-NAD+-dependent Histone/Protein Deacetylases* 210

  2002cited by this paper
• Human Sir2 and the 'silencing' of p53 activity.

  2002cited by this paper
• Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1*

  2002cited by this paper
• SIRT3, a human SIR2 homologue, is an NAD- dependent deacetylase localized to mitochondria

  2002cited by this paper
• Declining Influence of Race on the Outcome of Living‐Donor Renal Transplantation

  2002cited by this paper
• SIR2 family of NAD(+)-dependent protein deacetylases.

  2002cited by this paper
• Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence

  2002cited by this paper
• Structure of a Sir2 enzyme bound to an acetylated p53 peptide.

  2002cited by this paper
• hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

  2001cited by this paper
• Identification of a small molecule inhibitor of Sir2p

  2001cited by this paper
• Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening*

  2001cited by this paper
• The human histone deacetylase family.

  2001cited by this paper
• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  2001cited by this paper
• Characterization of Matrix Metalloproteinase Inhibitors: Enzymatic Assays

  2001cited by this paper
• Negative Control of p53 by Sir2 Promotes Cell Survival under Stress

  2001cited by this paper
• Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

  2000cited by this paper
• Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.

  2000cited by this paper
• Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.

  2000cited by this paper
• A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.

  1999cited by this paper
• Current protocols in pharmacology

  1998cited by this paper
• Localization of Sir2p: the nucleolus as a compartment for silent information regulators

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

  1985cited by this paper
• Human spleen histone H4. Isolation and amino acid sequence.

  1982cited by this paper

• Bioluminescence assay of lysine deacylase sirtuin activity.

  2024cites this paper
• Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds

  2024cites this paper
• Advances in direct detection of lysine methylation and acetylation by nuclear magnetic resonance using 13C-enriched cofactors

  2023cites this paper
• Continuous Fluorescent Sirtuin Activity Assay Based on Fatty Acylated Lysines

  2023cites this paper
• Bioluminescence Assay of Lysine Deacylase Sirtuin Activity

  2023cites this paper
• A study of SIRT1-and SIRT2-Mediated Deacetylation Using the Agilent RapidFire high-throughput mass spectrometry system

  2022cites this paper
• Continuous Sirtuin/HDAC (histone deacetylase) activity assay using thioamides as PET (Photoinduced Electron Transfer)-based fluorescence quencher.

  2021cites this paper
• Molecular imaging of NAD+‐dependent deacetylase SIRT1 in the brain

  2021cites this paper
• Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.

  2021cites this paper
• Recent advances in biosensor for histone acetyltransferase detection.

  2020cites this paper
• Electrochemical, electrochemiluminescent and photoelectrochemical bioanalysis of epigenetic modifiers: A comprehensive review

  2020cites this paper
• Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity

  2019cites this paper
• Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors

  2019cites this paper
• Improved mass spectrometry-based activity assay reveals oxidative and metabolic stress as sirtuin-1 regulators

  2019cites this paper
• One-Atom-Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity.

  2019cites this paper
• Exploration of the Fluorescent Properties and the Modulated Activities against Sirtuin Fluorogenic Assays of Chromenone-Derived Natural Products

  2018cites this paper
• A novel electrogenerated chemiluminescence biosensor for histone acetyltransferases activity analysis and inhibition based on mimetic superoxide dismutase of tannic acid assembled nanoprobes.

  2018cites this paper
• A Novel Substrate Radiotracer for Molecular Imaging of SIRT2 Expression and Activity with Positron Emission Tomography

  2018cites this paper
• Nutritional biomarkers: Current view and future perspectives

  2018cites this paper
• A series of novel indazole derivatives of Sirt 1 activator as osteogenic regulators.

  2017cites this paper
• SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion.

  2017cites this paper
• Interactions between sirtuins and fluorogenic small-molecule substrates offer insights into inhibitor design

  2017cites this paper
• Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells

  2017cites this paper
• Bioanalytical approaches for the detection of protein acetylation-related enzymes

  2016cites this paper
• Small-Molecules Targeting Sirtuin 1: A Patent Review (2012-2015)

  2016cites this paper
• An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3.

  2016cites this paper
• A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions

  2016cites this paper
• Biology, Chemistry, and Pharmacology of Sirtuins.

  2016cites this paper
• Development Of Novel Radiotracers For Pet Imaging Of Hdac-Mediated Epigenetic Regulation

  2016cites this paper
• A FRET-based assay for screening SIRT6 modulators.

  2015cites this paper
• Metabolism and epigenetics.

  2015cites this paper
• A FRET-based assay for screening SIRT5 specific modulators.

  2015cites this paper
• Specific Turn-On Fluorescent Probe with Aggregation-Induced Emission Characteristics for SIRT1 Modulator Screening and Living-Cell Imaging.

  2015cites this paper
• A Novel Continuous Assay for the Deacylase Sirtuin 5 and Other Deacetylases.

  2015cites this paper
• Studying sirtuin inhibitors with in silico and in vitro approaches

  2015influential citation
• A mini-review on Sirtuin activity assays.

  2015cites this paper
• Histone deacetylase activity assay.

  2015cites this paper
• Screening and profiling assays for HDACs and sirtuins.

  2015cites this paper
• Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.

  2014cites this paper
• SIRT6 Links Immune Response and Metabolism to Cancer

  2014cites this paper
• Fluorescent activity detection method for human-derived silent information regulator 5

  2014cites this paper
• Studying SIRT6 regulation using H3K56 based substrate and small molecules.

  2014cites this paper
• New assays and approaches for discovery and design of Sirtuin modulators

  2014influential citation
• SIRT6 Links Immune Response and Metabolism to

  2014cites this paper
• A fluorogenic assay for screening Sirt6 modulators.

  2013cites this paper
• Hyperbranched polyester-based fluorescent probe for histone deacetylase via aggregation-induced emission.

  2013cites this paper
• Chapter 9 - Histone Deacetylases as Cancer Chemoprevention Targets for Natural Products

  2012cites this paper
• A new nonpeptide substrate of human sirtuin in a capillary electrophoresis‐based assay. Investigation of the binding mode by docking experiments

  2012cites this paper
• Nucleolar accumulation of APE1 depends on charged lysine residues that undergo acetylation upon genotoxic stress and modulate its BER activity in cells

  2012cites this paper
• Over Expression of Wild Type or a Catalytically Dead Mutant of SIRTUIN 6 Does Not Influence NFκB Responses

  2012cites this paper
• Acetylation of malate dehydrogenase 1 promotes adipogenic differentiation via activating its enzymatic activity

  2012cites this paper
• Heterochromatin effects in Friedreich's ataxia and sexual dimorphism

  2012influential citation
• Advances in Label-Free Screening Approaches for Studying Sirtuin-Mediated Deacetylation

  2011influential citation
• Capillary electrophoresis-based sirtuin assay using non-peptide substrates.

  2011cites this paper
• WldS protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice

  2011cites this paper
• Sirtuin 1 (SIRT1)

  2011cites this paper
• Using the Agilent RapidFire High-throughput Mass Spectrometry System to study SIRT 1-and SIRT 2-mediated deacetylation Application Note Drug Discovery

  2011cites this paper
• Estudo in silico de inibidores de SIRT1

  2011cites this paper
• Sirtuins as Potential Drug Targets for Metabolic Diseases

  2011cites this paper
• Electrophoretically mediated microanalysis assay for sirtuin enzymes

  2010cites this paper
• SIRT1 Activation by Small Molecules

  2010cites this paper
• An integrated on‐chip sirtuin assay

  2010cites this paper
• Assays for histone deacetylases.

  2009cites this paper
• In Vitro Assays for Histone‐Modifying Enzymes

  2009cites this paper
• A continuous microplate assay for sirtuins and nicotinamide-producing enzymes.

  2009cites this paper
• Using nonfluorescent Förster resonance energy transfer acceptors in protein binding studies.

  2009cites this paper
• 9-Fluorenylmethoxycarbonyl-labeled peptides as substrates in a capillary electrophoresis-based assay for sirtuin enzymes.

  2009cites this paper
• A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

  2009cites this paper
• Histone deacetylase activity assay.

  2009cites this paper
• NAD and axon degeneration: From the Wlds gene to neurochemistry

  2009cites this paper
• High-throughput assays for sirtuin enzymes: a microfluidic mobility shift assay and a bioluminescence assay.

  2008cites this paper
• Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

  2008cites this paper
• Development of a capillary electrophoresis‐based assay of sirtuin enzymes

  2008cites this paper
• p53-, SIRT1-, and PARP-1-independent downregulation of p21WAF1 expression in nicotinamide-treated cells.

  2008cites this paper
• Biochemical characterization of Plasmodium falciparum Sir2, a NAD+-dependent deacetylase.

  2008cites this paper
• Multiple Peptide Synthesis to Identify Bioactive Hormone Structures

  2007cites this paper
• Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease.

  2007cites this paper
• SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation.

  2007cites this paper
• ABT-888 , an OrallyActive Poly ( ADP-Ribose ) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in PreclinicalTumorModels

  2007cites this paper
• ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

  2007cites this paper
• Plasmodium falciparum Sir2: an Unusual Sirtuin with Dual Histone Deacetylase and ADP-Ribosyltransferase Activity

  2007influential citation
• Sirt2 Regulates Adipocyte Differentiation Involving FoxO1 Acetylation/Deacetylation

  2007cites this paper
• The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.

  2006cites this paper
• Comparative and pharmacophore model for deacetylase SIRT1

  2006cites this paper
• Inhibition of SIRT1 Catalytic Activity Increases p53 Acetylation but Does Not Alter Cell Survival following DNA Damage

  2006cites this paper
• High-level bacterial expression and purification of human SirT2 protein for NMR studies.

  2006cites this paper
• SIRT1 stimulation by polyphenols is affected by their stability and metabolism.

  2006cites this paper
• Mechanism of Human SIRT1 Activation by Resveratrol*

  2005cites this paper
• In vitro assays for the determination of histone deacetylase activity.

  2005cites this paper
• The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells*

  2004cites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Rejuvenating Sirtuins: the Rise of a New Family of Cancer Drug Targets

  year unknowncites this paper